Soc. Generale Call 43 EVT 13.12.2.../ DE000SR6KZJ2 /
- - | Chg.- | Bid- | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
-EUR | - | - Bid Size: - |
- Ask Size: - |
EVOTEC SE INH O.N. | 43.00 EUR | 12/13/2023 | Call |
GlobeNewswire
2/15/2018
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
1/8/2018
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
11/29/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
10/27/2011
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire
9/9/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
9/5/2011
Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire
9/5/2011
Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire
8/18/2011
Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire
8/11/2011
Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire
8/11/2011
Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire
7/7/2011
Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire
6/30/2011
Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...